3/10
08:40 am
clrb
Cellectar Biosciences (CLRB) was upgraded by Maxim Group from "hold" to "buy". They now have a $10.00 price target on the stock.
Medium
Report
Cellectar Biosciences (CLRB) was upgraded by Maxim Group from "hold" to "buy". They now have a $10.00 price target on the stock.
3/4
10:17 am
clrb
Cellectar (CLRB) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Cellectar (CLRB) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
3/4
07:51 am
clrb
Cellectar Biosciences Reports Financial Results for Year Ended 2025 and Provides Corporate Updates [Yahoo! Finance]
Medium
Report
Cellectar Biosciences Reports Financial Results for Year Ended 2025 and Provides Corporate Updates [Yahoo! Finance]
3/4
07:15 am
clrb
Cellectar Biosciences Reports Financial Results for Year Ended 2025 and Provides Corporate Updates
Medium
Report
Cellectar Biosciences Reports Financial Results for Year Ended 2025 and Provides Corporate Updates
2/25
08:05 am
clrb
Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Wednesday, March 4, 2026
Low
Report
Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Wednesday, March 4, 2026
2/17
08:05 am
clrb
Cellectar Biosciences Expands Global Intellectual Property Estate
High
Report
Cellectar Biosciences Expands Global Intellectual Property Estate
1/9
08:05 am
clrb
Cellectar Biosciences to Highlight Strategic Initiatives for 2026 at Upcoming Biotech Showcase during 44th Annual JP Morgan Healthcare Conference
Medium
Report
Cellectar Biosciences to Highlight Strategic Initiatives for 2026 at Upcoming Biotech Showcase during 44th Annual JP Morgan Healthcare Conference